Formoterol via Turbuhaler® gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents

Respiratory Medicine

Volumn 94, Issue 7, 2000, Pages 661-667

  Gronnerod T A ^a   Von Berg, A ^b   Schwabe, G ^c   Soliman, S ^c  

^a Clinic for Allergy and Pulmonology   (Norway)

^b Marien Hospital   (Germany)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Adolescents; Asthma; Children; Exercise; Formoterol; Turbuhaler

Indexed keywords

FORMOTEROL; FORMOTEROL FUMARATE; GLUCOCORTICOID; PLACEBO; TERBUTALINE SULFATE;

ADOLESCENT; ARTICLE; BRONCHOSPASM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLD AIR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFECT; EXERCISE INDUCED ASTHMA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0343893652     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.0789     Document Type: Article

References (30)

1. Anderson S D, Silverman M, Godfrey S, Koning P. Exercise-induced asthma: A review. Br J Dis Chest. 69:1975;1-39.
2. Silverman M, Konig P, Godfrey S. Use of serial exercise tests to assess the efficacy and duration of action for asthma. Thorax. 28:1973;574-578.
3. Silverman M, Andersson S D. Standardisation of exercise tests in asthmatic children. Arch Dis Child. 47:1972;882-889.
4. Kattan M, Keens T G, Mellis C M, Levison H. The response to exercise in normal and asthmatic children. J Pediatr. 92:1978;718-721.
5. McFadden E R Jr, Pichurko B M, Bowman H F, Ingenito E, Burns S, Dowling N, Sloway J. Thermal mapping of the airway in humans. J Appl Physiol. 58:1985;564-570.
6. Lee T H, Andersson S D. Heterogeneity of mechanisms in exercise-induced asthma. Thorax. 40:1985;481-487.
7. Wjst M, Dold S, Reitmeir P, Wulff A, Nicolai T, von Mutuis E. Evaluation of cold air challenge data in a population sample using a model of bronchial obstruction. Pediatr Pulmonol. 15:1993;339-344.
8. Carlsen K-H, Engh G, Mork M, Schroder E. Cold air inhalation and exercise-induced bronchoconstriction in relationship to methacholine bronchial responsiveness: different patterns in asthmatic children and children with other chronic lung diseases. Respir Med. 92:1998;308-315.
9. Anderson S D, Seale J P, Ferris L, Schoefell R E, Lindsay D A. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol. 64:1979;612-624.
10. Francis P WJ, Krastins I RB, Levison H. Oral and inhaled salbutamol in the prevention of exercise-induced bronchospasm. Pediatrics. 66:1980;103-108.
11. Global Strategy for asthma management and prevention NHLBI/WHO workshop report, Adapted from National Institute of Health, National Heart, Lung and Blood Institute.
12. Pediatrics. 74:1984;155-156.
13. Townsend M, Feeny D H, Guyatt G H, Furlong W J, Seip A E, Dolovich J. Evaluation of the burden of illness for pediatric asthmatic patients and their parents. Ann Allergy. 67:1991;403-408.
14. Nocon A. Social and emotional impact of childhood asthma. Arch Dis Child. 65:1990;779-781.
15. Seberová E, Hartman P, Veverka J, Terl M, Fiserová J, Bengtsson T, Andersson A. Formoterol given by Turbuhaler had a rapid onset of action as sabutamol given by pMDI. Am J Respir Crit Care Med. 159:1999;A637.
16. Ringdal N, Derom E, Wåhlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. Respir Med. 92:1998;1017-1021.
17. ®. Eur Resp J. 14:1999;S62.
18. von Berg A, Papageorgiou Saxoni F, Wille S, Carillo T, Kattamis C, Helms P. 3-month treatment with formoterol Turbuhaler in children with asthma. Eur Resp J. 12:1998;S36.
19. Ekström T, Ringdal N, Sobradillo V, Runnerström E, Soliman S. Low dose formoterol Turbuhaler (Oxis) b. i.d. A 3-month placebo controlled comparison with terbutaline. Respir Med. 92:1998;1040-1045.
20. Ekström T, Ringdal N, Tukiainen P, Runnerström E, Soliman S. A 3-month comparison of formoterol (Oxis) with terbutaline (Bricanyl) via Turbuhaler. A placebo controlled study. Ann Allergy Asthma Immunol. 81:1998;225-230.
21. Boner A L, Spezia E, Piovesan P, Chiocca E, Maiocchi G. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med. 149:1994;935-939.
22. Vilsvik J, Ankerst J, Palmqvist M, Persson G, Scaanning J, Schwabe G, Johansson Å. Duration of protection of formoterol against exercise-induced bronchoconstriction during regular treatment with formoterol Turbuhaler b. i.d. in adult asthmatics. Am J Respir Crit Care Med. 159:1999;A858.
23. Am Rev Respir Dis. 136:1987;225-244.
24. Polgar G, Promadhat V. Pulmonary Function in Children, Technique and Standards. 1971;W.B. Saunders Company, London.
25. Henriksen J M, Agertoft L, Pedersen S. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. J Allergy Clin Immunol. 89:1992;1176-1182.
26. Godfrey S, Silverman M. Demonstration of placebo response in asthma by means of exercise testing. J Psychosom Res. 17:1973;293.
27. Green C P, Price J F. Prevention of exercise-induced asthma by inhaled salmeterol xinafoate. Arch Dis Child. 67:1992;1014-1017.
28. 2 -agonist. J Allergy Clin Immunol. 89:1992;844-849.
29. Becker A B, Simons F E. Formoterol a new long-acting selective beta 2-agonist, decrease airway responsiveness in children with asthma. Lung. 1990;99-102.
30. 2-agonist formoterol. Am Rev Respir Dis. 143:1991;998-1001.